UK Launches Meningitis B Vaccine Drive for 1M Young People
Is this a smart, targeted response or an incomplete fix that leaves too many young people unprotected?
Above: A student receives the Meningitis B vaccine at the University of Kent sports hall in Canterbury, England on March 19. Image credit: Dan Kitwood/Getty Images
The Spin
Pro-government narrative
The U.K.'s one-off Meningitis B vaccine drive for roughly a million young people is a smart, targeted response to a genuine public health threat. Offering two doses of Bexsero before the academic year starts directly shields those at the highest immediate risk before the usual autumn peak in meningitis cases.
Government-critical narrative
A one-off program will not fully close the U.K.'s Meningitis B protection gap — teens and young adults outside the narrow eligibility window remain at real risk. Second-year students, postgraduates and younger teenagers are simply left out. Until routine NHS access exists for all at-risk young people, this remains an incomplete fix.